Healthpeak Properties (NYSE:DOC – Get Free Report) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 1.760-1.780 for the period, compared to the consensus EPS estimate of 1.770.
Healthpeak Properties Price Performance
DOC stock opened at $19.54 on Tuesday. The stock has a 50-day moving average price of $19.86 and a two-hundred day moving average price of $19.15. Healthpeak Properties has a 12-month low of $15.70 and a 12-month high of $22.95. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The company has a market cap of $13.47 billion, a PE ratio of 10.08, a price-to-earnings-growth ratio of 2.29 and a beta of 1.01.
Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.02 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.41). The firm had revenue of $820.89 million for the quarter, compared to analyst estimates of $739.18 million. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%. The business’s revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.46 earnings per share. As a group, research analysts predict that Healthpeak Properties will post 1.77 EPS for the current year.
Healthpeak Properties Announces Dividend
Analysts Set New Price Targets
A number of analysts recently issued reports on DOC shares. Wells Fargo & Company dropped their target price on shares of Healthpeak Properties from $22.00 to $19.00 and set an “equal weight” rating for the company in a research report on Monday, October 19th. Royal Bank Of Canada lifted their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. Mizuho boosted their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, July 6th. Robert W. Baird increased their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research report on Thursday, August 13th. Finally, Citigroup raised their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Tuesday, August 11th. Four equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $21.60.
Read Our Latest Research Report on DOC
Trending Headlines about Healthpeak Properties
Here are the key news stories impacting Healthpeak Properties this week:
- Positive Sentiment: Healthpeak reported third-quarter adjusted FFO of $0.44 per share, ahead of the $0.43 analyst consensus, although below $0.46 a year earlier. FFO is a key performance measure for REIT investors. Healthpeak Q3 FFO and Revenues Surpass Estimates
- Positive Sentiment: The company increased its fiscal 2026 earnings guidance to $1.76-$1.78 per share. The midpoint of $1.77 matches consensus, while the raised outlook signals management remains confident in operating performance. Healthpeak Reports Third Quarter Results and Increases Guidance
- Positive Sentiment: Revenue rose 16.3% year over year to $820.9 million, and outpatient medical lease executions totaled 846,000 square feet through the quarter, supporting expectations for continued portfolio growth. Healthpeak Q3 Adjusted FFO Falls, Revenue Rises; Lifts 2026 Guidance
- Neutral Sentiment: Revenue exceeded one reported consensus estimate of $739.2 million but came in below a separate FactSet estimate of $889 million, making the quarter’s top-line performance appear mixed depending on the benchmark. Healthpeak Q3 Revenue Earnings Flash
- Negative Sentiment: GAAP EPS was just $0.02, substantially below the $0.43 consensus and down from $0.46 a year earlier. The earnings shortfall and lower year-over-year FFO remain risks for investors. Healthpeak Properties Quarterly Earnings
Healthpeak Properties Company Profile
Healthpeak Properties, Inc (NYSE:DOC) is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.
Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.
Further Reading
- Five stocks we like better than Healthpeak Properties
- SpaceX Sent Verizon and T-Mobile Stocks Tumbling—Did Wall Street Overreact?
- SpaceX Starlink’s Telecom Ground Game Takes Shape
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
